Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Genesys International Corporation Ltd

GENESYS
Geospatial

Genesys International Corporation Ltd is cheap for a reason. The P/E sits at the 33rd percentile of its own range, and the quarters are still getting worse.

The sharpest disagreement: the P/E sits at the 33rd percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn.

The price is in a downtrend (69 weeks in) while the P/E sits at the 33rd percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −31.6% year on year, and −16% of the last 3 years' profit arrived as cash. What settles it: whether the quarters turn before the discount closes.

Stage
Mixed
partial read
Price
₹272
−53.4% 1Y
P/E
31.4×
33rd pctile
of its own 10-year range
Revenue (Mar 26)
₹104 Cr
+10.6% YoY
Profit (Mar 26)
₹13.0 Cr
−31.6% YoY
Operating margin
33.0%
−20.0 pp YoY
ROCE
8%
FY26
ROIC
4.2%
vs WACC 12.0% → −7.8 pp
Cash conversion
−16%
of profit, last 3 FY
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified. PEG is the exception: the quarterly curve is not drawn at all. PEG asks what is being paid for growth — both sides of that division come from the source that could not be checked, so it is withheld instead of marked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Genesys International Corporation Ltd trades at ₹272, in a downtrend and 69 weeks into that stage. That is −24.5% against its own 200-day average. It sits at 15% of a 52-week range of ₹209 to ₹629. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).

Today the stock is in a downtrend — week 69 of stage 4, confirmed. At ₹272 it trades −24.5% versus its 200-day average and sits at 15% of its 52-week range (₹209–₹629).

Jul 26: ₹272 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−24.5% versus the 200-day line, week 69 of stage 4
Price50-day avg200-day avg
S4S2S4₹1,067₹837₹606₹376₹145₹272₹360Jul 23May 24Feb 25Nov 25Jul 26
S4S2S4₹1,067₹837₹606₹376₹145₹272₹360Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (546 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +392% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Genesys International Corporation Ltd trades at 31.4× P/E, near the bottom of its own range — cheaper only 33% of the time. Its long-run median P/E is 42.5×, measured across 9.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 31.4× is near the bottom of its own range — cheaper only 33% of the time, against a long-run median of 42.5× measured over 9.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 31.4× vs a 42.5× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 9.8-year window; loss-period spikes above 128× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 33% of the time
P/EMedianEPS (TTM) (quarterly)
137.3×₹23.3102.9×₹17.568.6×₹11.734.3×₹5.80.0×₹0.0×31.40×₹9Oct 16Dec 18Jan 22Jul 24Jul 26
137.3×₹23.3102.9×₹17.568.6×₹11.734.3×₹5.80.0×₹0.0×31.40×₹9Oct 16Jan 22Jul 26
P/E
31.4×
33rd percentile of 10y

Why the multiple sits where it does: over the past year annual EPS moved −44.8% against a −53.4% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +11.9%/yr price move, ~+39.5%/yr came from earnings growth and ~−27.6 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Genesys International Corporation Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 8.0% — the per-curve reads carry the story. The read is built from 10 quarters across 3 curves, on partial evidence.

Growth, year by year: revenue +5.5% in FY26, profit −41.1% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
87%240%56%95%25%−50%−6.2%−195%−37%−340%%%5.5%−41.1%FY16FY21FY26
87%240%56%95%25%−50%−6.2%−195%−37%−340%%%5.5%−41.1%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue rolling over, profit rolling over
RevenueProfitEPS
129%332%90%217%52%102%13%−12%−25%−127%%%10.6%−31.6%−44.8%Jun 23Sep 24Mar 26
129%332%90%217%52%102%13%−12%−25%−127%%%10.6%−31.6%−44.8%Jun 23Sep 24Mar 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
16%13%11%8.7%6.4%%8%FY23FY24FY26
16%13%11%8.7%6.4%%8%FY23FY24FY26
Revenue growth
Rolling over
latest +10.6% · span −14.6% to +60.0%
Profit growth
Falling
latest −31.6% · span −95.2% to +100.0%
ROCE
Stuck low
latest 8.0% · span 7.0%–15.0%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+5.5%+21.9%+32.6%+21.4%
Profit−41.1%+30.1%+32.4%
EPS−44.8%+15.6%+26.7%
Share price−53.4%−3.3%+11.9%+15.7%
Revenue YoY (Mar 26)
+10.6%
latest quarter vs a year ago
Profit YoY (Mar 26)
−31.6%
latest quarter vs a year ago
Revenue 10y
21.4%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

26.9/100 — rank 3 of 3 in Geospatial · 71% evidence confidence

Genesys International Corporation Ltd scores 26.9 out of 100 against the 3 companies it is compared with in Geospatial, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 4.7 + 9.2 + 10 + 3 = 26.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Genesys International Corporation Ltd reported ₹104 Cr of revenue in the Mar 26 quarter, +10.6% year on year. Over 10 years it has compounded at 21.4% a year. The last full year, FY26, came in at ₹328 Cr. The last four reported quarters add to ₹328 Cr.

FY26 revenue came in at ₹328 Cr (+5.5% on the year), capping 10 years at 21.4% compound. The latest quarter (Mar 26) printed ₹104 Cr, +10.6% year on year.

FY26 revenue ₹328 Cr (+5.5% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
21.4% a year over 10 years
RevenueYoY growth
35487%26656%17725%89−6.2%0−37%₹ Cr%₹3285.5%FY16FY21FY26
35487%26656%17725%89−6.2%0−37%₹ Cr%₹3285.5%FY16FY21FY26
Mar 26: ₹104 Cr (+10.6% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
112129%8490%5652%2813%0−25%₹ Cr%₹10410.6%Jun 23Sep 24Mar 26
112129%8490%5652%2813%0−25%₹ Cr%₹10410.6%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +7.4% growth against the decade's 21.4% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +5.5% over the last 4 quarters against +28.7%/yr over the last 8 — rolling over; TTM profit −41.1% vs +19.8%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Genesys International Corporation Ltd's operating margin is 33.0% in the Mar 26 quarter, −20.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −1.9% to 56.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 33.0%, −20.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −1.9%–56.0%.

🚨 Why the margin moved: operating margin went −20.1 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 33.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −1.9–56.0% band over 13 years
operating marginYoY change (pp)
61%30%44%12%27%−5.1%10%−22%−6.5%−40%%%33%−13%FY11FY20FY26
61%30%44%12%27%−5.1%10%−22%−6.5%−40%%%33%−13%FY11FY20FY26
Mar 26: 33.0% operating margin (−20.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
56%24%45%10%35%−3.5%25%−17%14%−31%%%33%−20%Jun 23Sep 24Mar 26
56%24%45%10%35%−3.5%25%−17%14%−31%%%33%−20%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Genesys International Corporation Ltd earned ₹13.0 Cr of net profit in the Mar 26 quarter, −31.6% year on year. Full-year FY26 profit was ₹33.0 Cr. The 10-year compound rate is 32.4%. That is 12.5% of the quarter's revenue. The same quarter a year earlier earned ₹19.0 Cr. 2 of the last 12 reported quarters were loss-making.

Mar 26 profit was ₹13.0 Cr, −31.6% year on year. On the full year, FY26 printed ₹33.0 Cr (−41.1%), and the 10-year compound rate is 32.4%.

FY26 profit ₹33.0 Cr (−41.1% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
32.4% a year over 10 years
Net profitYoY growth
65226%33132%238%−29−56%−61−149%₹ Cr%₹33−41.1%FY16FY21FY26
65226%33132%238%−29−56%−61−149%₹ Cr%₹33−41.1%FY16FY21FY26
Mar 26: ₹13.0 Cr (−31.6% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
23710%16494%8277%061%−7−155%₹ Cr%₹13−31.6%Jun 23Sep 24Mar 26
23710%16494%8277%061%−7−155%₹ Cr%₹13−31.6%Jun 23Sep 24Mar 26

🚨 Why profit moved: revenue contributed +10.6% and the margin −20.0 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −19.4% vs revenue +7.4%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years −16% of Genesys International Corporation Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹16.0 Cr of operating cash against ₹33.0 Cr of profit. After ₹69.0 Cr of capital spending, ₹−53.0 Cr was left as free cash.

FY26: operating cash of ₹16.0 Cr against reported profit of ₹33.0 Cr, leaving free cash of ₹−53.0 Cr after ₹69.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −16% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹16.0 Cr vs profit ₹33.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY17/FY23/FY24 reflects an acquisition year — point shown clipped.
−16% of 3-year profit arrived as cash
Operating cashNet profitFree cash
7018−34−85−137₹ Cr₹16₹33₹−53FY16FY21FY26
7018−34−85−137₹ Cr₹16₹33₹−53FY16FY21FY26
FY26: CFO = 48% of profit (three-year rate −16%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
343%188%34%−121%−276%%48%FY16FY21FY26
343%188%34%−121%−276%%48%FY16FY21FY26

🚨 Why conversion sits at −16%: the cash cycle stretched 78 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: conversion is below par and the cash cycle has stretched 78 days — the next section's job is to find where the cash is stuck.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Genesys International Corporation Ltd's cash conversion cycle runs 226 days in FY26, up from 148 days in FY21. Capital spending ran ₹230 Cr over the last 3 years. At FY26 sales of ₹328 Cr each day of that cycle holds about ₹0.9 Cr, so roughly ₹203 Cr sits inside the business at any moment.

FY26: debtors at 226 days (an asset-light business — no inventory to speak of) — for a full cycle of 226 days, looser than FY21's 148.

In money terms: at FY26 sales of ₹328 Cr, each day of the cycle holds about ₹0.9 Cr — so the 226-day loop keeps roughly ₹203 Cr sitting inside the business at any moment.

FY26: a 226-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+78 days vs FY21
Cash cycleDebtor days
361296232167102days226d226dFY11FY17FY20FY23FY26
361296232167102days226d226dFY11FY20FY26

On the investment side: capital spending of ₹230 Cr over the last 3 fiscal years against ₹164 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹1.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹69.0 Cr, work-in-progress ₹1.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
steady investment
CapexWork-in-progress
1851317621−33₹ Cr₹69₹1FY16FY18FY21FY23FY26
1851317621−33₹ Cr₹69₹1FY16FY21FY26

The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Genesys International Corporation Ltd earns a ROCE of 8% in FY26. That is up from a trough of −7% in FY21. Return on invested capital clears the cost of that capital by −7.8 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 10.1% net margin on 0.34× asset turns.

FY26 ROCE is 8%, recovered from a FY21 trough of −7% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 10.1% net margin × 0.34× asset turns × 1.38× balance-sheet leverage ≈ 4.7% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 4.2% − 12.0% = a −7.8 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 8% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 12-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY21's −7%
ROCEROIC (annual)WACC
45%31%17%3.1%−11%%8%4.3%FY11FY20FY26
45%31%17%3.1%−11%%8%4.3%FY11FY20FY26
Q4 FY26: ROCE 6.1% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
16%12%7.7%3.5%−0.6%%6.1%6.1%Q1 FY24Q2 FY25Q4 FY26
16%12%7.7%3.5%−0.6%%6.1%6.1%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Genesys International Corporation Ltd carries total debt of ₹173 Cr against shareholder equity of ₹705 Cr as of Mar 26, a debt-to-equity of 0.25 — effectively unlevered. On the annual view that ratio went from 0.11 in FY22 to 0.25 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹173 Cr against shareholder equity of ₹705 Cr — a debt-to-equity of 0.25. On the annual view, debt-to-equity went from 0.11 (FY22) to 0.25 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹173 Cr at 0.25× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
1870.26×1400.22×930.18×470.13×00.09×₹ Cr×₹1730.25×FY22FY24FY26
1870.26×1400.22×930.18×470.13×00.09×₹ Cr×₹1730.25×FY22FY24FY26
Mar 26: debt ₹173 Cr, debt-to-equity 0.25 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
1870.26×1400.22×930.17×470.12×00.08×₹ Cr×₹1730.25×Jun 23Sep 24Mar 26
1870.26×1400.22×930.17×470.12×00.08×₹ Cr×₹1730.25×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Foreign institutions cut 6.7 points of Genesys International Corporation Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 1.5% of the company. Promoters moved −6.4 points over the same window, to 31.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −6.7 points over 8 quarters to 1.5%; Promoters: −6.4 points over 8 quarters to 31.5%; Domestic institutions: +1.1 points over 8 quarters to 1.1%.

🚨 Why the register moved: foreign institutions drove it (−6.7 points), alongside promoters (−6.4 points) — distribution into the market’s bid.

Fiscal-year ends: promoters −6.4 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
69%50%32%13%−5.0%%31.5%2.3%2.6%63.5%Mar 24Mar 25Mar 26
69%50%32%13%−5.0%%31.5%2.3%2.6%63.5%Mar 24Mar 25Mar 26
Foreign institutions cut 6.7 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
71%52%33%14%−5.3%%31.5%1.5%1.1%65.9%Jun 23Dec 24Jun 26
71%52%33%14%−5.3%%31.5%1.5%1.1%65.9%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Genesys International Corporation Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Geospatial
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Ceinsys Tech LtdCEINSYS 65.3/100Favorable setup84% evidence ASLEEP 31.9/35 Revenue 58.1% · PAT 100% · OPM change 5 pp 95% evidence 21.5/25 ROCE 27.5% · OPM 24% 95% evidence 11.9/20 P/E 13.1× · PEG — 35% evidence 0.0/20 RS sector -15.6% · RS bench -28.5% · 1Y -44.9%0 of 12 weeks ahead 100% evidence
Exact sum: 31.9 + 21.5 + 11.9 + 0 = 65.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.6% and the one-year return is -44.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
2C.E. Info Systems LtdMAPMYINDIA 40.7/100Mixed-negative evidence91% evidence TURNING 10.8/35 Revenue 2.4% · PAT -8.2% · OPM change 6 pp 100% evidence 17.5/25 ROCE 19.1% · OPM 44% 100% evidence 9.4/20 P/E 62.9× · PEG 2.33 85% evidence 3.0/20 RS sector -10.3% · RS bench -11.7% · 1Y -35.6%3 of 10 weeks ahead 70% evidence
Exact sum: 10.8 + 17.5 + 9.4 + 3 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Genesys International Corporation Ltdthis pageGENESYS 26.9/100Adverse evidence71% evidence ASLEEP 4.7/35 Revenue 5.5% · PAT -41.1% · OPM change -20 pp 95% evidence 9.2/25 ROCE 8.2% · OPM 33% 95% evidence 10.0/20 P/E 31.4× · PEG — 0% evidence 3.0/20 RS sector -21.5% · RS bench -30.1% · 1Y -55.1%5 of 10 weeks ahead 70% evidence
Exact sum: 4.7 + 9.2 + 10 + 3 = 26.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Genesys International Corporation Ltd's share price today?

Genesys International Corporation Ltd trades at ₹272, −53.4% over the past year. The company is valued at ₹1,135 Cr. The stock sits at 15% of its 52-week range of ₹209–₹629, −24.5% versus its 200-day average. On the tape, the price is in a downtrend, 69 weeks in. — as of 31 July 2026.

What were Genesys International Corporation Ltd's latest quarterly results?

Genesys International Corporation Ltd reported revenue of ₹104 Cr and net profit of ₹13.0 Cr for the Mar 26 quarter. Revenue rose 10.6% and profit fell 31.6% year on year. Earnings per share were ₹2.96. The operating margin was 33.0%, 20.0 pp lower than a year earlier. — as of 31 July 2026.

What is Genesys International Corporation Ltd's revenue?

Genesys International Corporation Ltd reported revenue of ₹104 Cr in the Mar 26 quarter, +10.6% year on year. For the full FY26 fiscal year, revenue was ₹328 Cr (+5.5%). Over the last 10 years revenue compounded at 21.4% a year. — as of 31 July 2026.

What is Genesys International Corporation Ltd's profit?

Genesys International Corporation Ltd earned ₹13.0 Cr of net profit in the Mar 26 quarter, −31.6% year on year. Full-year FY26 profit was ₹33.0 Cr. The operating margin ran 33.0% in the latest quarter. — as of 31 July 2026.

What is Genesys International Corporation Ltd's market cap?

Genesys International Corporation Ltd's market capitalisation is ₹1,135 Cr at a share price of ₹272. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Genesys International Corporation Ltd's P/E ratio?

Genesys International Corporation Ltd trades at a P/E of 31.4×, at the 33rd percentile of its own 10-year range, against a long-run median of 42.5×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Genesys International Corporation Ltd pay a dividend?

Not in its latest year — Genesys International Corporation Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 6 of its last 13 reported fiscal years, so there is a history but no current dividend. — as of 31 July 2026.

Is Genesys International Corporation Ltd overvalued?

On its own history, Genesys International Corporation Ltd looks cheap against its own history: its P/E of 31.4× has been cheaper only 33% of the time in 10 years (long-run median 42.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is Genesys International Corporation Ltd growing?

Not right now — Genesys International Corporation Ltd's latest numbers are shrinking: latest-quarter revenue +10.6% year on year, profit −31.6%, and the margin −20.0 pp at 33.0%. The 10-year compound rates are 21.4% (revenue) and 32.4% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.

How is Genesys International Corporation Ltd performing?

Genesys International Corporation Ltd is in a downtrend, 69 weeks in. Its latest quarter's revenue rose 10.6% and profit fell 31.6% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.

What stage is Genesys International Corporation Ltd in?

Mixed — no clean majority across the growth curves, ROCE holding at 8.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +10.6% latest, profit growth −31.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.

Is Genesys International Corporation Ltd in an uptrend?

No — the price is in a downtrend (week 69 of stage 4), trading −24.5% versus its 200-day average and at 15% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is Genesys International Corporation Ltd beating the market?

Not lately — on a trailing-13-week view Genesys International Corporation Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +392% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.

Will Genesys International Corporation Ltd's share price go up?

This page publishes no price forecast for Genesys International Corporation Ltd. What it measures instead: the share price is ₹272, the price is in a downtrend 69 weeks in. Its P/E of 31.4× sits at the 33rd percentile of its own 10-year range. — as of 31 July 2026.

Who owns Genesys International Corporation Ltd?

Promoters hold 31.5% of Genesys International Corporation Ltd, foreign institutions 1.5%, domestic institutions 1.1% and the public 65.9% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 6.7 points over 8 quarters. — as of 31 July 2026.

Does Genesys International Corporation Ltd have too much debt?

No — Genesys International Corporation Ltd's debt-to-equity is 0.25, and operating profit covers the interest bill 9×. FY26 borrowings were ₹173 Cr against equity of ₹704 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is Genesys International Corporation Ltd's capex?

Genesys International Corporation Ltd spent ₹230 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹69.0 Cr, with ₹1.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Genesys International Corporation Ltd's cash flow?

Genesys International Corporation Ltd generated ₹16.0 Cr of operating cash flow in FY26 and ₹−53.0 Cr of free cash flow after ₹69.0 Cr of capital spending. Reported profit that year was ₹33.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is Genesys International Corporation Ltd's profit real cash?

Not fully — over the last 3 fiscal years, −16% of Genesys International Corporation Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹16.0 Cr against reported profit of ₹33.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.

Where is Genesys International Corporation Ltd in its business cycle?

Genesys International Corporation Ltd's FY26 operating margin was 33.0%, against a 13-year band of −1.9%–56.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 33.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Genesys International Corporation Ltd story?

The sharpest disagreement: the P/E sits at the 33rd percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Genesys International Corporation Ltd a stock worth studying right now?

This is not investment advice. The machine read: Genesys International Corporation Ltd is cheap for a reason. The P/E sits at the 33rd percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the quarters turn before the discount closes. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI